• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TERUMO BCT SPECTRA OPTIA; SPECTRA OPTIA IDL SET

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TERUMO BCT SPECTRA OPTIA; SPECTRA OPTIA IDL SET Back to Search Results
Model Number 10310
Device Problems Patient-Device Incompatibility (2682); Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Fever (1858); Reaction (2414)
Event Date 10/19/2019
Event Type  malfunction  
Manufacturer Narrative
Investigation is in process.A follow-up report will be provided.
 
Event Description
The customer reported that after 1.5 total blood volume (tbv) was processed on a spectra optia device, a pediatric patient started shivering and had a high grade fever.Per the customer's medical officer the patient was given iv calcium gluconate, injection avil, injection hydrocot and injection merowin.Per the customer the patient is reported as "recovered stable".The patient identifier is not available from the customer.The disposable set is not available for return because it was discarded by the customer.
 
Manufacturer Narrative
This report is being filed to provide additional information in investigation: a review of the device history record (dhr) for this unit showed no irregularities during manufacturing that were relevant to this issue.According to therapeutic apheresis: a physician's handbook, adverse events occur during therapeutic procedures with a frequency of 4.8%.Transient hypocalcemia associated with apheresis is usually well tolerated.Symptoms often show as paresthesia (tingling) but patients may also experience unusual taste, nausea, lightheadedness, shivering, and tremors.Severe hypocalcemia may also cause muscle contractions and can progress to tetany and seizures if hypocalcemia escalates and is not corrected.Investigation is in process.A follow-up report will be provided.
 
Manufacturer Narrative
This report is being filed to provide additional information in h.10.Investigation: the optia essentials guide advises the operator of possible adverse effects of apheresis procedures and to be prepared to take appropriate action should any reactions occur.Some previously reported reactions are: anxiety, headache, light-headedness, digit and/or facial paresthesia, fever, chills, hematoma, hyperventilation, nausea and vomiting, syncope (fainting), urticaria, hypotension, and allergic reactions.Investigation is in process.A follow-up report will be provided.
 
Manufacturer Narrative
This report is being filed to provide additional information in b.6, h.6 and h.10.Investigation: the run data file (rdf) was analyzed for this event.Root cause: no definitive root cause for the reported adverse patient reactions could be identified from the rdf associated with this procedure.It is important to monitor the connector and collect port for clumping especially if the run has been paused for more than 3 minutes due to alarms or patient issues.At 114 minutes into the run, the pumps were paused for over 3 minutes which was evidenced by large variations seen in the rg ratio signals afterwards when the run resumed.This may occur if there was clumping and/or could be related to patient blood physiology.If clumping is identified or suspected, it is recommended to decrease the ratio to 8 and leave it there until the clumping has resolved.In summary, a definitive root cause for the donor's reaction could not be determined.Possible causes include, but are not limited to ac management during the procedure and/or donor sensitivity to anticoagulant.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SPECTRA OPTIA
Type of Device
SPECTRA OPTIA IDL SET
Manufacturer (Section D)
TERUMO BCT
lakewood CO 80215
MDR Report Key9310335
MDR Text Key166177156
Report Number1722028-2019-00341
Device Sequence Number1
Product Code GKT
UDI-Device Identifier05020583103108
UDI-Public05020583103108
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional
Type of Report Initial,Followup,Followup,Followup
Report Date 11/12/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/12/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date03/01/2021
Device Model Number10310
Device Catalogue Number10310
Device Lot Number1903063131
Was Device Available for Evaluation? No
Was the Report Sent to FDA? Yes
Date Manufacturer Received04/30/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Other; Required Intervention;
Patient Age00014 YR
Patient Weight58
-
-